Nektar Therapeutics | Des Atouts





Des Atouts Changement Date
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
ALKERMES USD 2.49B 157.48M 2025-12
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Amgen USD 90.59B 445M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
Biogen USD 29.44B 232M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Cara Therapeutics USD 43.75M 4.8M 2025-06
Cipla INR 401.64B 27.77B 2025-09
Dr.Reddys Laboratories INR 562.9B 20.89B 2025-12
Eisai JPY 1.49T 48.22B 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Esperion Therapeutics USD 364.02M 16.93M 2025-09
Exelixis USD 2.84B 20.87M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Grifols EUR 23.29B 3.35M 2025-09
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
MacroGenics USD 270.76M 25.34M 2025-09
Merck USD 129.55B 12.02B 2025-09
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Takeda JPY 15.41T 938.47B 2025-12
Teva Pharmaceutical Industries USD 40.75B 892M 2025-12
Xencor USD 875.5M 6.68M 2025-12


Nektar Therapeutics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.